Clinicopathological Significance of Claudin-6 Immunoreactivity in Low-grade, Early-stage Endometrioid Endometrial Carcinoma

In Vivo, Год журнала: 2024, Номер 39(1), С. 367 - 374

Опубликована: Дек. 31, 2024

Dysregulation of claudin 6 (CLDN6) expression has been widely documented in various malignancies. CLDN6 is aberrantly expressed many types human carcinomas; however, its clinical significance endometrial carcinoma seldom investigated. This study aimed to examine the immunohistochemical status low-grade, early-stage endometrioid (LGES-EEC) and assess clinicopathological significance.

Язык: Английский